243 related articles for article (PubMed ID: 29850985)
1. The Use of Ommaya Reservoirs to Deliver Central Nervous System-Directed Chemotherapy in Childhood Acute Lymphoblastic Leukaemia.
Wilson R; Osborne C; Halsey C
Paediatr Drugs; 2018 Aug; 20(4):293-301. PubMed ID: 29850985
[TBL] [Abstract][Full Text] [Related]
2. Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research Hospital.
Gaietto A; Panetta JC; Pauley JL; Relling MV; Ribeiro R; Ehrhardt MJ; Pui CH; Inaba H; Swanson HD
Cancer Chemother Pharmacol; 2024 Jun; 93(6):617-625. PubMed ID: 38416167
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal chemotherapy with antineoplastic agents in children.
Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
[TBL] [Abstract][Full Text] [Related]
4. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Barba D
J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
[TBL] [Abstract][Full Text] [Related]
5. Lumbar spinal fluid collections in children treated with intrathecal chemotherapy: elevated CSF protein as a diagnostic clue.
Almanjomi F; Armstrong D; Abla O; Naqvi A; Weitzman S; Hitzler J
Pediatr Blood Cancer; 2008 Aug; 51(2):295-8. PubMed ID: 18454469
[TBL] [Abstract][Full Text] [Related]
6. Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoir.
Bleyer WA; Poplack DG
Med Pediatr Oncol; 1979; 6(3):207-13. PubMed ID: 288969
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism of toxic injury to the Papez circuit from chemotherapy.
Kwan BY; Krings T; Bernstein M; Mandell DM
J Clin Neurosci; 2015 Apr; 22(4):760-2. PubMed ID: 25564269
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous cerebrospinal fluid reservoirs in patients with acute leukaemia.
Spiers AS; Booth AE; Firth JL
Scand J Haematol; 1978 Apr; 20(4):289-96. PubMed ID: 274806
[TBL] [Abstract][Full Text] [Related]
9. Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.
Manabe A; Tsuchida M; Hanada R; Ikuta K; Toyoda Y; Okimoto Y; Ishimoto K; Okawa H; Ohara A; Kaneko T; Koike K; Sato T; Sugita K; Bessho F; Hoshi Y; Maeda M; Kinoshita A; Saito T; Tsunematsu Y; Nakazawa S
J Clin Oncol; 2001 Jul; 19(13):3182-7. PubMed ID: 11432884
[TBL] [Abstract][Full Text] [Related]
10. Catheter placement for Ommaya reservoirs with frameless surgical navigation: technical note.
Greenfield JP; Schwartz TH
Stereotact Funct Neurosurg; 2008; 86(2):101-5. PubMed ID: 18073523
[TBL] [Abstract][Full Text] [Related]
11. Development of the Metronomic Biofeedback Pump for leptomeningeal carcinomatosis: technical note.
Chen TC; Napolitano GR; Adell F; Schönthal AH; Shachar Y
J Neurosurg; 2015 Aug; 123(2):362-72. PubMed ID: 25955873
[TBL] [Abstract][Full Text] [Related]
12. Intracranial Hemorrhage Following Intrathecal Methotrexate Therapy for Acute Lymphoblastic Leukaemia.
Purkait R; Dolai TK; Lath C; Das B
Indian Pediatr; 2016 May; 53(5):423-4. PubMed ID: 27254055
[TBL] [Abstract][Full Text] [Related]
13. [Use of Ommaya reservoirs in the treatment of meningeal relapse of acute lymphoblastic leukemia].
Janvier M; Leverger G; Renier D; Poirier O; Tobelem G; Boiron M
Nouv Rev Fr Hematol (1978); 1984; 26(5):295-8. PubMed ID: 6594669
[TBL] [Abstract][Full Text] [Related]
14. Variability in the disposition of intraventricular methotrexate: a proposal for rational dosing.
Strother DR; Glynn-Barnhart A; Kovnar E; Gregory RE; Murphy SB
J Clin Oncol; 1989 Nov; 7(11):1741-7. PubMed ID: 2809687
[TBL] [Abstract][Full Text] [Related]
15. Chemoport with a non-collapsible chamber as a replacement for an Ommaya reservoir in the treatment of leptomeningeal carcinomatosis.
Gwak HS; Lee CH; Yang HS; Joo J; Shin SH; Yoo H; Lee JS; Lee SH
Acta Neurochir (Wien); 2011 Oct; 153(10):1971-8; discussion 1978. PubMed ID: 21796363
[TBL] [Abstract][Full Text] [Related]
16. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
Estlin EJ; Yule SM; Lowis SP
Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
[TBL] [Abstract][Full Text] [Related]
17. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
Zając-Spychała O; Wachowiak J
Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
[TBL] [Abstract][Full Text] [Related]
19. Lack of functionality and need for revision of an Ommaya reservoir placed into a cavum septum pellucidum.
Mascitelli J; De Los Reyes K; Steinberger J; Zou H
J Neurosurg; 2013 Mar; 118(3):502-4. PubMed ID: 23121429
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
Shapiro WR; Young DF; Mehta BM
N Engl J Med; 1975 Jul; 293(4):161-6. PubMed ID: 806016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
